Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice.
van den Broek DAJ, Meziyerh S, Budde K, Lefaucheur C, Cozzi E, Bertrand D, López Del Moral C, Dorling A, Emonds MP, Naesens M, de Vries APJ; ESOT Working Group Subclinical DSA Monitoring. van den Broek DAJ, et al. Among authors: lopez del moral c. Transpl Int. 2023 Jul 25;36:11321. doi: 10.3389/ti.2023.11321. eCollection 2023. Transpl Int. 2023. PMID: 37560072 Free PMC article.
Non-HLA Antibodies and Their Role in Highly Sensitized Patients.
Roa-Bautista A, López-Del-Moral C, González-López E, Gutiérrez-Larrañaga M, Renuncio-García M, Castro-Hernández C, Mikhalkovich-Mikhalkovich D, Comins-Boo A, Irure-Ventura J, Rodrigo E, Ruiz San Millán JC, López-Hoyos M, San Segundo D. Roa-Bautista A, et al. Among authors: lopez del moral c. Transplant Proc. 2022 Nov;54(9):2439-2442. doi: 10.1016/j.transproceed.2022.10.011. Epub 2022 Oct 29. Transplant Proc. 2022. PMID: 36319497
The natural history of de novo donor-specific HLA antibodies after kidney transplantation.
López Del Moral C, Wu K, Naik M, Osmanodja B, Akifova A, Lachmann N, Stauch D, Hergovits S, Choi M, Bachmann F, Halleck F, Schrezenmeier E, Schmidt D, Budde K. López Del Moral C, et al. Front Med (Lausanne). 2022 Sep 16;9:943502. doi: 10.3389/fmed.2022.943502. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36186822 Free PMC article.
Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions.
Wu K, Schmidt D, López Del Moral C, Osmanodja B, Lachmann N, Halleck F, Choi M, Bachmann F, Ronicke S, Duettmann W, Naik M, Schrezenmeier E, Rudolph B, Budde K. Wu K, et al. Among authors: lopez del moral c. Front Med (Lausanne). 2022 May 12;9:889648. doi: 10.3389/fmed.2022.889648. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35646957 Free PMC article.
Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination-specific humoral and cellular immunity in kidney transplant recipients.
Schrezenmeier E, Rincon-Arevalo H, Jens A, Stefanski AL, Hammett C, Osmanodja B, Koch N, Zukunft B, Beck J, Oellerich M, Proß V, Stahl C, Choi M, Bachmann F, Liefeldt L, Glander P, Schütz E, Bornemann-Kolatzki K, López Del Moral C, Schrezenmeier H, Ludwig C, Jahrsdörfer B, Eckardt KU, Lachmann N, Kotsch K, Dörner T, Halleck F, Sattler A, Budde K. Schrezenmeier E, et al. Among authors: lopez del moral c. JCI Insight. 2022 May 9;7(9):e157836. doi: 10.1172/jci.insight.157836. JCI Insight. 2022. PMID: 35349490 Free PMC article.
Poor Long-Term Renal Allograft Survival in Patients with Chronic Antibody-Mediated Rejection, Irrespective of Treatment-A Single Center Retrospective Study.
Wu K, Schmidt D, López Del Moral C, Osmanodja B, Lachmann N, Zhang Q, Halleck F, Choi M, Bachmann F, Ronicke S, Duettmann W, Naik MG, Schrezenmeier E, Rudolph B, Budde K. Wu K, et al. Among authors: lopez del moral c. J Clin Med. 2021 Dec 30;11(1):199. doi: 10.3390/jcm11010199. J Clin Med. 2021. PMID: 35011939 Free PMC article.